CVS Health Corp (NYSE:CVS) shares, rose in value, with the stock price up by 3.61% to the previous day’s close as strong demand from buyers drove the stock to $65.50.
Actively observing the price movement in the recent trading, the stock is buoying the session at $63.22, falling within a range of $63.56 and $65.82. The value of beta (5-year monthly) is 0.543 whereas the PE ratio is 17.91 over 12-month period. Referring to stock’s 52-week performance, its high was $80.75, and the low was $43.56. On the whole, CVS has fluctuated by 27.01% over the past month.
With the market capitalization of CVS Health Corp currently standing at about $82.43 billion, investors are eagerly awaiting this quarter’s results, scheduled for in March. The company’s Forward Dividend Ratio is 2.66, with its dividend yield at 4.06%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 387.23B, with a low estimate of 91.5B and a high estimate of 96.05B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 93.22B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CVS’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 1.23, with the price of CVS currently trading nearly 17.27% and 26.50% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 80.44, while the 7-day volatility ratio is showing 3.42% which for the 30-day chart, stands at 2.89%. Furthermore, CVS Health Corp (CVS)’s beta value is 0.55, and its average true range (ATR) is 2.13.
A comparison of CVS Health Corp (CVS) with its peers suggests the former has fared considerably weaker in the market. CVS showed an intraday change of 3.61% in today’s session so far, and over the past year, it shrunk by -15.25%%.
Data on historical trading for CVS Health Corp (NYSE:CVS) indicates that the trading volumes over the past 10 days have averaged 12.63 and over the past 3 months, they’ve averaged 13.49 million. According to company’s latest data on outstanding shares, there are 1.26 billion shares outstanding.
Nearly 0.20% of CVS Health Corp’s shares belong to company insiders and institutional investors own 82.01% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 21.35 million shares as on 2025-01-31, resulting in a short ratio of 1.6. According to the data, the short interest in CVS Health Corp (CVS) stood at 170.00 of shares outstanding as of 2025-01-31; the number of short shares registered in 2024-12-31 reached 18.1 million. The stock has risen by 45.91% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CVS stock heading into the next quarter.
